Why there is no single liver-mass department
A liver mass is a finding, not a diagnosis. It can be a benign lesion such as a haemangioma or focal nodular hyperplasia, a cyst, an infection-related collection, or a primary or secondary cancer. Each possibility points to a different clinical team, and the same patient may move between teams as results come in.
In Chinese tertiary hospitals, the department names you will see on an appointment system reflect this. Hepatobiliary surgery (often written as hepatobiliary and pancreatic surgery) manages masses that may need resection or that sit close to major vessels and bile ducts. Gastroenterology or hepatology manages masses in the context of chronic liver disease, cirrhosis or infection, and often coordinates biopsy and surveillance. Medical oncology manages confirmed or strongly suspected malignancy that may need systemic therapy. Interventional radiology or a dedicated liver tumour centre may lead if ablation or embolisation is being considered.
The practical consequence for an overseas patient is that choosing a department before anyone has looked at the images can waste an appointment. The better first question is not 'which department?' but 'what does the imaging suggest, and who in this hospital leads that pathway?'
What the imaging usually tells the team
The character of the lesion on contrast imaging drives the routing. A mass with typical features of a benign haemangioma may be managed with reassurance and follow-up rather than surgery. A lesion in a cirrhotic liver with arterial enhancement and washout raises concern for hepatocellular carcinoma, which changes both the department and the urgency. Multiple lesions may suggest metastatic disease and prompt a search for a primary tumour elsewhere.
This is why a written report alone is often insufficient for a first decision. The receiving clinician usually wants the actual images, ideally on disc or through a link the hospital can open, plus the report that describes the contrast phases. If you have had more than one scan, the comparison between them matters as much as either scan alone.
Blood tests add context rather than a diagnosis. Liver function tests, clotting, a full blood count, hepatitis B and C status and tumour markers are commonly relevant, but their interpretation belongs to the treating team. Do not assume a normal tumour marker excludes cancer or that a raised one confirms it; ask the clinician what the result means in your case.
The records that make a first appointment useful
A first consultation in a busy Chinese tertiary hospital is short. The clinician needs to see the evidence quickly, in a form that can be read without you explaining every page. Organise the file before you travel, and keep a copy with you.
Imaging is the core. Bring the original discs or a working download link for every CT, MRI or ultrasound, together with the written reports. If a biopsy has been done, bring the pathology report and, where possible, the slides or blocks, because a Chinese hospital may wish to review the tissue itself rather than accept an outside conclusion.
Laboratory results should include dates and units. Liver function, clotting, blood counts, viral hepatitis serology and any tumour markers are the usual starting set. A concise medication list, including anticoagulants, herbal products and supplements, matters because some affect bleeding risk and liver tests. A short summary of prior surgery, chronic liver disease, alcohol use and family history of liver disease helps the clinician frame the case.
Keep the summary to one page. A long narrative tends to be skipped; a clear timeline with dates, findings and treatments is read.
- Imaging discs or links plus written reports, oldest to newest
- Pathology report and tissue blocks or slides if a biopsy was taken
- Dated laboratory results with units
- Medication list including anticoagulants, herbs and supplements
- One-page timeline of prior treatment and relevant history
When more than one specialty needs to be in the room
Some liver masses sit between specialties. A tumour that might be resectable but also might respond to systemic therapy, a mass in a cirrhotic liver where future liver reserve is uncertain, or a lesion near the bile ducts all benefit from more than one opinion. In China, larger hospitals run multidisciplinary team meetings, often called MDT, where surgery, oncology, radiology and pathology discuss selected cases together.
Access to an MDT is not automatic. It usually depends on the hospital's own criteria and on whether the case is accepted for discussion. If you are considering a complex case, ask the hospital whether an MDT review is part of its pathway for your situation and what records it requires. A records-based multidisciplinary review can also be arranged before travel through a coordination service, but that review informs planning; it does not establish that the hospital will accept you for treatment or that a particular procedure is available.
The distinction matters. A review can clarify which specialty should lead and what further information is missing. It cannot replace an in-person assessment, and it does not guarantee surgical suitability.
Public tertiary hospitals and international departments
Chinese public tertiary hospitals concentrate complex liver work, but their outpatient systems are busy and appointments can be difficult to arrange from abroad. Some hospitals have international departments or VIP clinics that offer English-language support and a more structured visit, usually at a higher charge. Others do not, and you may be seen in the standard clinic with an interpreter.
There is no single rule that every overseas patient should use an international department. Ask the specific hospital what route your appointment will take, who will interpret, and whether the clinician reviewing your records is the same person who will see you in clinic. Those answers affect how useful the first visit is.
Hospital consultation fees, tests, treatment and rooms are paid to the hospital. Coordination and interpretation services are separate and are agreed in advance. Ask for a written outline of what each part covers rather than assuming a single bundled price.
Questions to settle before you commit to a trip
Before booking travel, clarify the clinical question the visit is meant to answer. Is it to confirm the nature of the mass, to assess whether surgery is possible, to plan systemic treatment, or to obtain a second opinion on an existing plan? The answer determines which department and which records matter most.
Ask the hospital or coordinating team directly: which department will review the images first; whether a pathologist will re-examine any biopsy tissue; what additional tests are likely to be requested in China and whether they can be done in one visit; and what the written estimate covers. Do not rely on a general statement that a hospital is 'good for liver' — ask about the specific pathway for your finding.
Also ask about language. Liver discussions involve nuance about risk, alternatives and prognosis. If interpretation is needed, confirm who provides it and whether they are clinically familiar with the terminology. A family member with basic English may not be sufficient for a consent conversation.
Finally, keep your local clinicians informed. A mass may need monitoring or treatment regardless of travel plans, and decisions about timing should involve the team that knows your history. If symptoms worsen, seek local assessment rather than waiting for an overseas appointment.
A practical next step
Start with a short summary: the imaging report, the date of the most recent scan, any biopsy result and your main question. An initial enquiry with ChinaSpecialistCare is free and is a non-clinical check of whether the records are complete enough to route your question to the right specialty. It is not a diagnosis and does not promise hospital acceptance. From there, you can decide whether a specialist appointment, a records-based opinion or a multidisciplinary review is the sensible next move, and you can request a written outline of fees and scope before committing.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
